A scale from hard no to green light
Not all retinoids are equal. Between a capsule of isotretinoin and a 0.5% retinyl palmitate cream lies a thousandfold difference in bioavailability. The question "are retinoids OK in pregnancy" without specifying the form has no answer.
Red: oral isotretinoin (Accutane)
Systemic retinoid for severe nodulocystic acne. Teratogenic effect documented and uncontested.
- FDA category X – absolute contraindication.
- iPLEDGE program requires two contraceptive methods plus monthly pregnancy tests.
- Known embryopathies: craniofacial defects, CNS malformations, cardiac defects.
- Washout: at least 1 month after the last capsule before conception.
Non-negotiable. Isotretinoin in reproductive-age women requires serious contraception.
Orange: topical tretinoin and adapalene
Tretinoin
On paper, FDA category C. In practice, dermatologists do not prescribe topical tretinoin in pregnancy out of caution.
Evidence:
- Loureiro et al., 2005 (Reproductive Toxicology 20:389) – retrospective cohort of 106 first-trimester exposures. No increase in congenital defects vs control.
- Jick et al., 1993 – similar conclusion on 215 cases.
But samples are small, systemic absorption through a damaged barrier is theoretically possible, and a rare complication is easy to miss. Standard recommendation: discontinue before trying to conceive.
Adapalene
Even less pregnancy data. Category C. Same approach – discontinue.
Yellow: topical retinol
Retinol converts to retinoic acid in skin through two steps. Efficacy is 10–20x lower than tretinoin. Systemic bioavailability of topical retinol is estimated at under 0.1% – less than a thousandth of the applied dose reaches circulation.
No direct prohibition, no direct permission either. No large RCTs on pregnant women with retinol will ever run. Dermatologists default to:
Retinol in pregnancy – probably no. Not because harm is proven, but because safety is not.
If a pregnancy starts during retinol use, no reason to panic – bioavailability is tiny. But continuing the course is not advised.
Green: retinyl palmitate
Ester of retinol and palmitic acid. Needs to split into retinol, then convert to retinaldehyde, then to retinoic acid. Every step loses activity. Effective potency is about 20x lower than retinol, 200–400x lower than tretinoin. Found in basic moisturizers, sunscreens as antioxidant, body oils. No clinically meaningful pregnancy risk.
Safer alternative: bakuchiol
Plant compound from Psoralea corylifolia. Not structurally a retinoid but partially activates RAR receptors.
- Dhaliwal et al., 2019 – comparable cosmetic effect to retinol over 12 weeks with better tolerability.
- No pregnancy-specific data, but low systemic absorption and a non-retinoid structure make it the sensible swap.
Practical algorithm
Planning pregnancy:
- Stop oral isotretinoin at least a month before.
- Stop topical tretinoin and adapalene.
- Retinol – stop or discuss with dermatologist.
- Retinyl palmitate in a moisturizer is fine.
- Swap to: vitamin C (LAA or ethyl ascorbate), peptides, bakuchiol, niacinamide, SPF.
Already pregnant with exposure:
- Oral isotretinoin – see a doctor immediately.
- First-trimester tretinoin – follow standard OB screenings. Loureiro 2005 data is reassuring.
- Retinol – stop now, no panic.
- Retinyl palmitate – don't worry.
Breastfeeding:
- Isotretinoin – no.
- Tretinoin, retinol – usually postpone.
- Retinyl palmitate, bakuchiol – fine.
Pregnancy is not a reason to abandon skincare. It's a reason to pick simpler forms with longer safety records.